Dabigatran Etexilate Mesylate
Who holds supplier records for Dabigatran Etexilate Mesylate? 37 organisations hold a current record for Dabigatran Etexilate Mesylate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (24), China (7), Netherlands (1), Canada (1) and 2 other countries (2); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dabigatran Etexilate Mesylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dabigatran-etexilate-mesylate
Reading the evidence
- 37 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
24 of the 35 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 22 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (37)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dabigatran Etexilate Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 28177, 44582 · latest filing Aug 2026
- Neuland Laboratories LimitedIndiaActive DMF 28352, 38769 · latest filing Mar 2025
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 27781 · latest filing Dec 2013
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 37002 · latest filing Apr 2022
- Biocon LimitedIndiaCEPActive DMF 33112 · latest filing Sept 2018
- CHANGZHOU PHARMACEUTICAL FACTORYChinaCEP Company GMP cert on recordActive DMF 37528 · latest filing Nov 2022
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 27960 · latest filing Apr 2014
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 40122, 31613 · latest filing Jun 2024
- METROCHEM API PRIVATE LTDIndiaCEPActive DMF 37633 · latest filing Oct 2022
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 27037 · latest filing Jun 2013
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 35362 · latest filing Jan 2021
- Piramal Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 30404 · latest filing Mar 2016
- Sichuan Qingmu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 36539 · latest filing Dec 2021
- TAPI NL BVNetherlandsCEPActive DMF 28118 · latest filing Apr 2014
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 28419 · latest filing Jul 2014
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 28285 · latest filing May 2014
- ACEBRIGHT INDIA PHARMA PRIVATE LTDIndiaActive DMF 35360 · latest filing Oct 2020
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 36794 · latest filing Feb 2022
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 28231 · latest filing May 2014
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 28442 · latest filing Jul 2014
- Apotex Inc.CanadaActive DMF 28029 · latest filing Mar 2014
- HISUN PHARMACEUTICAL NANTONG CO LTDActive DMF 32941 · latest filing Jun 2018
- Jiangxi Synergy Pharmaceutical Co., LtdChinaActive DMF 32782 · latest filing Apr 2018
- JUBILANT BIOSYS LTDIndiaActive DMF 31383 · latest filing Mar 2017
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 36181 · latest filing Nov 2021
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 28039 · latest filing Apr 2014
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 29668 · latest filing Sept 2015
- OPTIMUS DRUGS PRIVATE LTDIndiaActive DMF 35132 · latest filing Dec 2020
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 30460 · latest filing Apr 2016
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 35253 · latest filing Sept 2020
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 28395 · latest filing Aug 2014
- Yabao Pharmaceutical Group Co., Ltd.ChinaActive DMF 35226 · latest filing Dec 2020
- ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDChina Company GMP cert on recordActive DMF 43560 · latest filing Feb 2026
- IndiaCEP Company GMP cert on record
- SpainCEP Company GMP cert on record
- ChinaCEP
- KRKA TOVARNA ZDRAVIL D.D.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (18)
Certificates of Suitability on the EDQM register for Dabigatran Etexilate Mesylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2025-167 - Rev 00 Dabigatran etexilate mesilate | Nov 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2023-458 - Rev 01 Dabigatran etexilate mesilate, Micronised and non-micronised | Sept 2026 | Inspected May 2026 Italy |
| METROCHEM API PRIVATE LIMITED Hyderabad | IN | CEP 2024-130 - Rev 01 Dabigatran etexilate mesilate | Jul 2026 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | CEP 2025-197 - Rev 00 Dabigatran etexilate mesilate, Non-micronised, Micronised | Jun 2026 | Inspected Apr 2025 Spain |
| SICHUAN QINGMU PHARMACEUTICAL CO., LTD. Meishan City | CN | CEP 2024-115 - Rev 00 Dabigatran etexilate mesilate | Jun 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2024-081 - Rev 01 Dabigatran etexilate mesilate, Form-I | May 2026 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2024-365 - Rev 00 Dabigatran etexilate mesilate, Form 1, Process II | May 2026 | — |
| PIRAMAL PHARMA LIMITED Digwal Village | IN | CEP 2024-090 - Rev 00 Dabigatran etexilate mesilate, Form-I | Mar 2026 | Inspected Jun 2025 Netherlands |
| TAPI NL B.V. Amsterdam | NL | CEP 2025-606 - Rev 00 Dabigatran etexilate mesilate, Form I, ACL | Mar 2026 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2024-073 - Rev 02 Dabigatran etexilate mesilate, Micronised, non-micronised | Dec 2025 | — |
| HIKAL LIMITED Bangalore | IN | CEP 2024-363 - Rev 00 Dabigatran etexilate mesilate | Dec 2025 | Inspected Nov 2025 Switzerland |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2023-382 - Rev 00 Dabigatran etexilate mesilate | Nov 2025 | — |
| KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto | SI | CEP 2024-152 - Rev 00 Dabigatran etexilate mesilate, Micronised | Oct 2025 | Inspected Jul 2025 Slovenia |
| BIOCON LIMITED Pashamylaram | IN | CEP 2024-046 - Rev 00 Dabigatran etexilate mesilate, Form-I | Oct 2025 | — |
| Changzhou Pharmaceutical Factory Changzhou | CN | CEP 2023-435 - Rev 00 Dabigatran etexilate mesilate | Aug 2025 | Inspected Apr 2025 Italy |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2024-262 - Rev 00 Dabigatran etexilate mesilate, Form-I | Jun 2025 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Chandampet Village | IN | CEP 2024-026 - Rev 00 Dabigatran etexilate mesilate, Crystalline Form-I, micronised and non-micronised | Dec 2024 | Inspected Oct 2025 Slovakia |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2024-012 - Rev 00 Dabigatran etexilate mesilate, Crystalline Form-I, Micronised and Non-micronised | Oct 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Dabigatran Etexilate Mesylate are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- SICHUAN RENAN PHARMACEUTICAL CO LTDInactive DMF 38099 · filed Apr 2023
- ESTEVE QUIMICA SAInactive DMF 29270 · filed Jun 2015
- India · Inactive DMF 27892 · filed Mar 2014
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dabigatran Etexilate Mesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1615369).
Chemical identity
- IUPAC name
- ethyl 3-[[2-[[4-[(E)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid
- Canonical SMILES
- CCCCCCOC(=O)/N=C(\C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)/N.CS(=O)(=O)O
- InChIKey
- XETBXHPXHHOLOE-UHFFFAOYSA-N
- Synonyms
- BIBR 1048 MS, BIBR-1048-MS, Dabigatran etexilate accord, Dabigatran etexilate leon farma, Dabigatran etexilate mesilate, Dabigatran etexilate mesylate, Pradaxa, Pradaxa (dabigatran etexilate mesylate), Rendix, Pradaxa, Dabigatran etexilate mesylate, BS-1008
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Direct Thrombin Inhibitor
- Mechanism of action
- Thrombin Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dabigatran Etexilate Mesylate?
37 organisations hold an active US FDA Type II Drug Master File or a CEP for Dabigatran Etexilate Mesylate: Hetero Drugs Limited (India), Neuland Laboratories Limited (India), Alembic Pharmaceuticals Limited (India), Aurore Life Sciences (India), Biocon Limited (India), CHANGZHOU PHARMACEUTICAL FACTORY (China), Dr. Reddy's Laboratories Ltd. (India) and HIKAL LTD (India), and 29 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dabigatran Etexilate Mesylate Drug Master Files are active?
Hetero Drugs Limited (DMF 28177, 44582), Neuland Laboratories Limited (DMF 28352, 38769), Alembic Pharmaceuticals Limited (DMF 27781), Aurore Life Sciences (DMF 37002), Biocon Limited (DMF 33112), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 37528), Dr. Reddy's Laboratories Ltd. (DMF 27960) and HIKAL LTD (DMF 40122, 31613) and 25 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dabigatran Etexilate Mesylate records mean?
3 organisations have only inactive Type II DMFs for Dabigatran Etexilate Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dabigatran Etexilate Mesylate have a European Certificate of Suitability?
Yes. 18 organisations hold a valid CEP for Dabigatran Etexilate Mesylate on the EDQM register, including LAURUS LABS LIMITED Hyderabad (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), METROCHEM API PRIVATE LIMITED Hyderabad (IN), QUIMICA SINTETICA S.A. Alcala De Henares (ES), SICHUAN QINGMU PHARMACEUTICAL CO., LTD. Meishan City (CN) and ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dabigatran Etexilate Mesylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dabigatran Etexilate Mesylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.